中国循环杂志
中國循環雜誌
중국순배잡지
CHINESE CIRCULATION JOURNAL
2014年
10期
841-845
,共5页
郝青青%张永欢%于庆涛%朱莉%陈旭%李树英%张月辉%董波%李瑞峰
郝青青%張永歡%于慶濤%硃莉%陳旭%李樹英%張月輝%董波%李瑞峰
학청청%장영환%우경도%주리%진욱%리수영%장월휘%동파%리서봉
动脉粥样硬化%血管紧张素转换酶2%血凝素样氧化型低密度脂蛋白受体-1%基因
動脈粥樣硬化%血管緊張素轉換酶2%血凝素樣氧化型低密度脂蛋白受體-1%基因
동맥죽양경화%혈관긴장소전환매2%혈응소양양화형저밀도지단백수체-1%기인
Atherosclerosis%Angiotensin converting enzyme 2%Lectin-like oxidized low density lipoprotein receptor-1%Gene
目的:探讨血管紧张素转换酶2(ACE2)基因转染对内皮细胞血凝素样氧化型低密度脂蛋白受体-1(LOX-1)表达的影响及意义。方法:实验包括体外实验与体内实验。体外实验,首先进行人脐静脉内皮细胞(HUVEC)的培养,然后应用蛋白质印迹法检测ACE2转染对血管紧张素II刺激HUVEC产生的LOX-1蛋白表达的影响。体内实验,首先建立载脂蛋白E基因敲除(ApoE-/-)小鼠动脉粥样硬化模型。然后将20只ApoE-/-小鼠随机分为ACE2组及增强型绿色荧光蛋白组(EGFP组),每组10只。ACE2组经尾静脉注射ACE2的复制缺陷重组腺病毒(Ad-ACE2)(2.5×109 pfu/ml),EGFP组注射等量EGFP的复制缺陷重组腺病毒(Ad-EGFP)。注射一个月后处死动物,做腹主动脉的油红O及LOX-1表达的检测。结果:体内实验与体外实验均证实ACE2基因转染抑制了内皮细胞LOX-1的表达,体内实验中ACE2组斑块内脂质含量明显低于EGFP组水平。结论:ACE2通过抑制LOX-1的表达进而抑制了动脉粥样硬化斑块的进展。
目的:探討血管緊張素轉換酶2(ACE2)基因轉染對內皮細胞血凝素樣氧化型低密度脂蛋白受體-1(LOX-1)錶達的影響及意義。方法:實驗包括體外實驗與體內實驗。體外實驗,首先進行人臍靜脈內皮細胞(HUVEC)的培養,然後應用蛋白質印跡法檢測ACE2轉染對血管緊張素II刺激HUVEC產生的LOX-1蛋白錶達的影響。體內實驗,首先建立載脂蛋白E基因敲除(ApoE-/-)小鼠動脈粥樣硬化模型。然後將20隻ApoE-/-小鼠隨機分為ACE2組及增彊型綠色熒光蛋白組(EGFP組),每組10隻。ACE2組經尾靜脈註射ACE2的複製缺陷重組腺病毒(Ad-ACE2)(2.5×109 pfu/ml),EGFP組註射等量EGFP的複製缺陷重組腺病毒(Ad-EGFP)。註射一箇月後處死動物,做腹主動脈的油紅O及LOX-1錶達的檢測。結果:體內實驗與體外實驗均證實ACE2基因轉染抑製瞭內皮細胞LOX-1的錶達,體內實驗中ACE2組斑塊內脂質含量明顯低于EGFP組水平。結論:ACE2通過抑製LOX-1的錶達進而抑製瞭動脈粥樣硬化斑塊的進展。
목적:탐토혈관긴장소전환매2(ACE2)기인전염대내피세포혈응소양양화형저밀도지단백수체-1(LOX-1)표체적영향급의의。방법:실험포괄체외실험여체내실험。체외실험,수선진행인제정맥내피세포(HUVEC)적배양,연후응용단백질인적법검측ACE2전염대혈관긴장소II자격HUVEC산생적LOX-1단백표체적영향。체내실험,수선건립재지단백E기인고제(ApoE-/-)소서동맥죽양경화모형。연후장20지ApoE-/-소서수궤분위ACE2조급증강형록색형광단백조(EGFP조),매조10지。ACE2조경미정맥주사ACE2적복제결함중조선병독(Ad-ACE2)(2.5×109 pfu/ml),EGFP조주사등량EGFP적복제결함중조선병독(Ad-EGFP)。주사일개월후처사동물,주복주동맥적유홍O급LOX-1표체적검측。결과:체내실험여체외실험균증실ACE2기인전염억제료내피세포LOX-1적표체,체내실험중ACE2조반괴내지질함량명현저우EGFP조수평。결론:ACE2통과억제LOX-1적표체진이억제료동맥죽양경화반괴적진전。
Objective: To investigate the inlfuence of angiotensin converting enzyme 2 (ACE2) on lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) protein expression and to explore the protective effect of ACE2 on vascular endothelial cells. Methods: Our work includedin vitro andin vivo studies. For in vitro experiment, the human umbilical vein endothelial cell (HUVEC) were cultured and transfected with replication deficient recombinant adenovirus of ACE2 (Ad-ACE2), and LOX-1 protein expression stimulated by angiotensin 2 was examined by Western blot analysis. Forin vivo study, atherosclerosis plaques were induced in 20 apolipoprotein E-deifcient (ApoE-/-) mice, and then randomly divided them into 2 groups: ACE2 group, the mice received Ad-ACE2 (2.5×109 pfu/ml) injection through caudal vein, EGFP (enhanced green lfuorescent protein) group, the mice received equal replication deifcient recombinant adenovirus of EGFP (Ad-EGFP) injection through caudal vein.n=10 in each group. The animals were executed after 1 month treatment to collect abdominal aorta. Lipid content in atherosclerosis plaque was evaluated by Oil red O staining and LOX-1 protein expression was examined by immunohistochemistry and Western blot analysis. Results: Bothin vitro andin vivo experiments conifrmed that endothelial cell LOX-1 protein expression was signiifcantly inhibited by ACE2 transfection. The lipid content in ACE2 group was obviously lower than that in EGFP group byin vivo study. Conclusion: ACE2 may inhibit LOX-1 protein expression and therefore reduce the progress of atherosclerosis.